TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer

Published:2001 Issue:6 Volume:3 Page:535-546
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Srivastava Rakesh K.

Publisher

Elsevier BV

Subject

Cancer Research

Reference145 articles.

1. Human ICE/CED-3 protease nomenclature;Alnemri;Cell,1996

2. Death receptors: signaling and modulation;Ashkenazi;Science,1998

3. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J Clin Invest,1999

4. NF-kappa B: ten years after;Baeuerle;Cell,1996

5. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation;Banner;Cell,1993

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib promotes the TRAIL-mediated killing of resistant rhabdomyosarcoma by ErbB2/Her2-targeted CAR-NK-92 cells via DR5 upregulation;Molecular Therapy: Oncology;2024-06

2. ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2);Molecular Biology Reports;2024-05-24

3. Enzyme-activatable disk-shaped nanocarriers augment tumor permeability for breast cancer combination therapy;Nano Research;2024-04-04

4. Aponermin: First Approval;Drugs;2024-03-05

5. Isolation of bioactive phytochemicals from Crinum asiaticum L. along with their cytotoxic and TRAIL-resistance abrogating prospect assessment;Heliyon;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3